Senescence-associated secretory proteins induced in lung adenocarcinoma by extended treatment with dexamethasone enhance migration and activation of lymphocytes
Prahlad Parajuli(Eugene Applebaum College of Pharmacy and Health Sciences), Manohar Ratnam(Wayne State University), Aroma Naeem(Eugene Applebaum College of Pharmacy and Health Sciences), Navnath S. Gavande(Wayne State University), Zahin Hussain(Eugene Applebaum College of Pharmacy and Health Sciences), Robert E. Wright(Eugene Applebaum College of Pharmacy and Health Sciences), Lisa Polin(Wayne State University), Sijana H. Dzinic(Wayne State University), Rayna Rosati(Wayne State University), Hirva Mamdani(Wayne State University)
Cited by 14
Related Papers
Immunotherapy in Lung Cancer: Current Landscape and Future Directions
|Frontiers in Immunology|2022|373
Therapy for Stage IV Non–Small-Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline
|Journal of Clinical Oncology|2022|125
Therapy for Stage IV Non–Small-Cell Lung Cancer With Driver Alterations: ASCO Living Guideline
|Journal of Clinical Oncology|2022|116
Histone Deacetylase Inhibition in Non-small Cell Lung Cancer: Hype or Hope?
|Frontiers in Cell and Developmental Biology|2020|80
Blood-based tumor biomarkers in lung cancer for detection and treatment
|Translational Lung Cancer Research|2017|75